The short version
Koya Medical, Inc. is a corporation organized in Delaware (formed 2018), based in Oakland, CA.
What this means A deal company is usually set up for one investment; its Form D is the notice it files after selling to investors.
It has filed 1 Form D filing (Dec 30, 2020) for 1 offering, industry reported as "Other" under Rule 506(b): $11M sold of $11M offered to 12 investors, minimum investment $1, first sale Dec 15, 2020.
What this means 100% of the target was sold by the filing date — about $918K per investor. Rule 506(b) means no public advertising; up to 35 non-accredited investors may take part.
Key people as listed: Anand Doraiswamy (executive officer and director), Jan Garfinkle (director) and Josh Baltzell (director).
What this means These are the people the company itself named as running or promoting it. Tap a name to see every other deal they are on.
No sales commissions, finder's fees or proceeds to insiders are reported. No sales-compensation recipients are listed.
What this means No broker was paid — the sponsor sold it directly to investors.
Activity: 0 new offerings in the last 12 months; no amendment on file; latest filing Dec 30, 2020.
What this means No new raise filed in the past year — this deal company may be done raising, or simply quiet.
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Koya Medical, Inc..
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY), property records (NYC, FL, IL and TX counties) — 1 property record listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.